TrialBreast cancer research and treatment2023

Neoadjuvant carboplatin in triple-negative breast cancer: results from NACATRINE, a randomized phase II clinical trial.

Cristiano de Pádua Souza et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.